Zobrazeno 1 - 6
of 6
pro vyhledávání: '"K. D. Dorogoykina"'
Publikováno v:
Архивъ внутренней медицины, Vol 12, Iss 3, Pp 221-227 (2022)
Aim to determine the clinical and laboratory relationships of the level of soluble stimulating growth factor expressed by genome 2 (sST2) with indicators characterizing the development of cardiovascular pathology in patients with spondyloarthritis (S
Externí odkaz:
https://doaj.org/article/28bf3792265746d1a118e08092a7652f
Publikováno v:
Архивъ внутренней медицины, Vol 11, Iss 4, Pp 284-291 (2021)
Aim: to study parameters of arterial stiffness and subclinical atherosclerosis in patients with axial spondyloarthritis (axSpA) without clinically manifest cardiovascular pathology depending on the presence of anemia.Material and methods. 102 patient
Externí odkaz:
https://doaj.org/article/23ff5b9e4c5a4c5f82f1f9ddf0cee6bd
Publikováno v:
Архивъ внутренней медицины, Vol 10, Iss 3, Pp 217-222 (2020)
Aim — to study the frequency of peripheral joint damage and the incidence of osteophytes in patients with ankylosing spondylitis.Materials and methods. 124 patients with ankylosing spondylitis corresponding to the international New York criteria of
Externí odkaz:
https://doaj.org/article/f7b8f556eb504974ab4c8457b3fea7b5
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 47, Iss 5, Pp 410-418 (2019)
Background: Anemia is a frequent comorbid conditions in patients with spondyloarthritis (SpA). Its development is associated with the activity of the underlying disorder, and in some cases can be a complication of medical treatment. Investigation int
Externí odkaz:
https://doaj.org/article/3bf9b37ac2134d21902ba1cd50809022
Publikováno v:
Kardiologiia. 59(11)
We present here the case of development of dilated cardiomyopathy in a patient with HIV infection. The results of dynamic monitoring and treatment (cardiotropic and antiretroviral therapy) for 4 years are described. We also discuss literature data on
Publikováno v:
Terapevticheskii arkhiv. 89:78
To compare the efficiency and safety of two celecoxib regimens in the short-term treatment of patients with axial spondyloarthritis (axSpA).Examinations were made in 40 patients with axSpA (the 2009 ASAS criteria; age, 38.5±12.1 years; 29 (72.5%) me